Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 ShsAbbott Laboratories Shs Cert Deposito Arg Repr 0.25 ShsAbbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs

Abbott Laboratories Shs Cert Deposito Arg Repr 0.25 Shs

No trades
See on Supercharts
Market capitalization
‪345.45 T‬ARS
2,050ARS
‪12.23 T‬ARS
‪38.41 T‬ARS
Beta (1Y)
0.00

About Abbott Laboratories


CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Founded
1888
ISIN
ARDEUT110608
FIGI
BBG000HDMMT8
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Check out other big names from the same industry as ABT.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
S
ABT3985539
St. Jude Medical, LLC 4.75% 15-APR-2043
Yield to maturity
6.60%
Maturity date
Apr 15, 2043
US2824BH2
Abbott Laboratories 4.9% 30-NOV-2046
Yield to maturity
5.21%
Maturity date
Nov 30, 2046
ABT4466215
Abbott Laboratories 4.75% 15-APR-2043
Yield to maturity
5.01%
Maturity date
Apr 15, 2043
ABT.HB
Abbott Laboratories 5.3% 27-MAY-2040
Yield to maturity
4.89%
Maturity date
May 27, 2040
ABT.GX
Abbott Laboratories 6.0% 01-APR-2039
Yield to maturity
4.81%
Maturity date
Apr 1, 2039
ABT.GW
Abbott Laboratories 6.15% 30-NOV-2037
Yield to maturity
4.72%
Maturity date
Nov 30, 2037
ABLC
Abbott Laboratories 4.75% 30-NOV-2036
Yield to maturity
4.65%
Maturity date
Nov 30, 2036
US2824BQ2
Abbott Laboratories 1.4% 30-JUN-2030
Yield to maturity
3.98%
Maturity date
Jun 30, 2030
US2824BF6
Abbott Laboratories 3.75% 30-NOV-2026
Yield to maturity
3.78%
Maturity date
Nov 30, 2026
ABT5005071
Abbott Laboratories 1.15% 30-JAN-2028
Yield to maturity
3.69%
Maturity date
Jan 30, 2028
A
XS207615510
Abbott Ireland Financing DAC 0.375% 19-NOV-2027
Yield to maturity
2.42%
Maturity date
Nov 19, 2027

See all ABT bonds